drugset / Trial / NCT07390747
A Trial of SHR-2173 in Healthy Volunteers
RandomizedSingle-groupQuadruple-blindTreatment
Summary
The purpose of this study is to assess safety, PK, Pharmacodynamic and immunogenicity profile of a single dose of SHR-2173 in healthy participants
Timeline
- Start
- 2026-03-06
- Primary completion
- 2026-05-22
- Completion
- 2026-08-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | SHR-2173 | Unknown | — | Subcutaneous |
Indications
No indication recorded.